Natco Pharma Ltd 524816
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 975.70
- Day Range
- INR 981.70–996.00
- 52-Week Range
- INR 609.55–1,107.85
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 177.19 Bil
- Volume/Avg
- 13,881 / 56,034
Key Statistics
- Price/Earnings (Normalized)
- 13.75
- Price/Sales
- 4.61
- Dividend Yield (Trailing)
- 0.96%
- Dividend Yield (Forward)
- 0.51%
- Total Yield
- 2.47%
Company Profile
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 3,391
- Website
- https://www.natcopharma.co.in
Comparables
Valuation
|
Metric
|
524816
|
524348
|
532612
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.75 | 25.63 | 22.04 |
Price/Book Value | 3.30 | 3.40 | 2.74 |
Price/Sales | 4.61 | 1.72 | 1.65 |
Price/Cash Flow | 14.31 | 19.39 | 12.23 |
Price/Earnings
524816
524348
532612
Financial Strength
|
Metric
|
524816
|
524348
|
532612
|
|---|---|---|---|
Quick Ratio | 2.67 | 0.91 | 0.86 |
Current Ratio | 3.81 | 1.66 | 1.76 |
Interest Coverage | 138.30 | 8.03 | 5.10 |
Quick Ratio
524816
524348
532612
Profitability
|
Metric
|
524816
|
524348
|
532612
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.10% | — |
Return on Equity (Normalized) | — | 13.89% | — |
Return on Invested Capital (Normalized) | — | 10.74% | — |
Return on Assets
524816
524348
532612
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yknpcjyl | Fmt | $76.6 Bil | |
MKKGY
| Merck KGaA ADR | Mjwcfhqz | Mklssg | $72.3 Bil | |
HLN
| Haleon PLC ADR | Znkwvgxj | Dzgt | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Qhnhnfvm | Msx | $18.3 Bil | |
VTRS
| Viatris Inc | Mwjfzwzdz | Sfj | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kvvjgntq | Pqtx | $11.8 Bil | |
CTLT
| Catalent Inc | Rvgjycld | Nclgs | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mvrtbppj | Rcsv | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Lygbkxw | Bft | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dsxmcthxb | Kjhvtg | $3.5 Bil |